CompletedNCT01797575
N-Acetylcysteine and Aspirin for Bipolarity
About this title
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
Read the official source — NCT01797575Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- HoustonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 38
- Sponsor
- The University of Texas Health Science Center, Houston
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01797575
- Official title
Show the full official title
A Double-blind Randomized Placebo-controlled Study of Aspirin and N-acetyl Cysteine as Adjunctive Treatments for Bipolar Disorder Patients (SMRI 11T-009)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center, Houston, a university.
Did this study involve medication?
Yes. The study involved medication, including Aspirin and Sugar Pill.
Who was this study for?
Listed age limits: 18 years to 65 years.
